Here are the latest quarterly results of GLAND PHARMA. For more details, see the GLAND PHARMA financial fact sheet and GLAND PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
| No. of Mths Qtr. Ending |
3
Mar-24* |
3
Jun-24* |
3
Sep-24* |
3
Dec-24* |
3
Mar-25* |
3
Jun-25* |
3
Sep-25* |
3
Dec-25* |
8-Qtr Chart Click to enlarge |
|
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | Rs m | 15,375 | 14,017 | 14,058 | 13,841 | 14,249 | 15,056 | 14,869 | 16,954 | |
| Other income | Rs m | 421 | 514 | 597 | 585 | 440 | 575 | 842 | 632 | |
| Turnover | Rs m | 15,796 | 14,531 | 14,655 | 14,425 | 14,689 | 15,631 | 15,710 | 17,585 | |
| Expenses | Rs m | 11,788 | 11,373 | 11,088 | 10,241 | 10,774 | 11,379 | 11,730 | 12,605 | |
| Gross profit | Rs m | 3,587 | 2,644 | 2,971 | 3,600 | 3,475 | 3,678 | 3,139 | 4,105 | |
| Depreciation | Rs m | 926 | 920 | 938 | 963 | 958 | 1,011 | 1,063 | 1,076 | |
| Interest | Rs m | 100 | 56 | 61 | 228 | 75 | 115 | 78 | 39 | |
| Profit before tax | Rs m | 2,982 | 2,182 | 2,568 | 2,993 | 2,883 | 3,127 | 2,839 | 3,621 | |
| Tax | Rs m | 1,058 | 745 | 932 | 946 | 1,018 | 973 | 1,002 | 1,007 | |
| Profit after tax | Rs m | 1,924 | 1,438 | 1,635 | 2,047 | 1,865 | 2,155 | 1,837 | 2,615 | |
| Gross profit margin | % | 23.3 | 18.9 | 21.1 | 26.0 | 24.4 | 24.4 | 21.1 | 24.2 | |
| Effective tax rate | % | 35.5 | 34.1 | 36.3 | 31.6 | 35.3 | 31.1 | 35.3 | 27.8 | |
| Net profit margin | % | 12.5 | 10.3 | 11.6 | 14.8 | 13.1 | 14.3 | 12.4 | 15.4 | |
| Diluted EPS | Rs | 11.7 | 8.7 | 9.9 | 12.4 | 11.3 | 13.1 | 11.1 | 15.9 | |
| Diluted EPS (TTM) | Rs | 46.9 | 43.8 | 42.0 | 42.8 | 42.4 | 46.8 | 48.0 | 51.4 | |
Although the benchmark indices opened lower, they traded negative throughout the session and ultimately closed red.